Exploring the impact of neoadjuvant therapy on fluorescence-guided surgery for bone and soft tissue sarcomas: A narrative review
European Journal of Surgical Oncology · 2026-11 · 52 (11) · 112110
DOI: 10.1016/j.ejso.2026.112110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Surgical Oncology, 2026-11. Verfasst von Anne-Fleur S Verhaar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, University Medical Center Groningen, Groningen, the Netherlands; TRACER Europe B.V., Groningen, the Netherlands. Ele…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Sarcoma, Bone Neoplasms, Surgery, Computer-Assisted. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Surgical resection is an important curative treatment for patients with bone and soft tissue sarcomas, often preceded by neoadjuvant therapy to reduce tumor size, enhance resectability and improve oncological outcomes. Fluorescence-guided surgery (FGS) has emerged as a promising technique to enhance intraoperative tumor visualization and resection precision. However, the impact of neoadjuvant therapy on the efficacy of FGS remains an area of ongoing investigation. This narrative review explores the current existing literature on the relationship between neoadjuvant therapies and the effectiveness of fluorescence-guided sarcoma surgery, identifying what has been learned from previous studies implementing FGS, and to hypothesize what is relevant for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, University Medical Center Groningen, Groningen, the Netherlands; TRACER Europe B.V., Groningen, the Netherlands. Electronic address: a.s.verhaar@umcg.nl.
- Department of Surgical Oncology, University Medical Center Groningen, Groningen, the Netherlands.
- Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- TRACER Europe B.V., Groningen, the Netherlands.
Zitieren
APA
Verhaar, A. S., Stevenson, M. G., Houdt, W. J. V., Ginkel, R. J. V., Dam, G. M. V., & Kruijff, S. (2026). Exploring the impact of neoadjuvant therapy on fluorescence-guided surgery for bone and soft tissue sarcomas: A narrative review. European Journal of Surgical Oncology, 52(11), 112110. https://doi.org/10.1016/j.ejso.2026.112110
Vancouver
Verhaar AS, Stevenson MG, Houdt WJV, Ginkel RJV, Dam GMV, Kruijff S. Exploring the impact of neoadjuvant therapy on fluorescence-guided surgery for bone and soft tissue sarcomas: A narrative review. European Journal of Surgical Oncology. 2026;52(11):112110. doi:10.1016/j.ejso.2026.112110
BibTeX
@article{Verhaar2026,
author = {Verhaar, Anne-Fleur S and Stevenson, Marc G and Houdt, Winan J van and Ginkel, Robert J van and Dam, Gooitzen M van and Kruijff, Schelto},
title = {Exploring the impact of neoadjuvant therapy on fluorescence-guided surgery for bone and soft tissue sarcomas: A narrative review},
journal = {European Journal of Surgical Oncology},
year = {2026},
volume = {52},
number = {11},
pages = {112110},
doi = {10.1016/j.ejso.2026.112110}
}
EUVIMED